Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
Pembrolizumab led to significantly longer progression-free survival than chemotherapy when received as first-line therapy for MSI-H-dMMR metastatic colorectal cancer, with fewer...